GPT Healthcare reports strong Q2, H1 FY26 financial growth and declares dividend

GPT Healthcare Limited reported robust financial performance for the second quarter and half-year ended September 30, 2025. Total revenue from operations for Q2 FY26 reached ₹11,890.80 lakhs, contributing to a half-year total of ₹22,601.66 lakhs. This marks a substantial increase compared to ₹10,566.28 lakhs in total revenue for Q2 FY25. Net profit after tax for the quarter was ₹1,060.44 lakhs, bringing the half-year net profit to ₹1,828.62 lakhs.

The company's earnings per equity share (of ₹10 each) for Q2 FY26 stood at ₹1.29 (basic & diluted), with the half-year figure at ₹2.23. The board of directors has declared an interim dividend of 10%, equivalent to ₹1 per equity share of ₹10 each. The record date for determining eligible shareholders for this interim dividend is set for November 14, 2025.

These unaudited financial results, along with the notice of the record date for the interim dividend, have been published in accordance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.